Christopher H. Hunter is the CEO of Acadia Healthcare Company, starting his role on April 11, 2022. He previously held senior leadership positions at Humana, where he was involved in shaping strategies for their group and specialty sectors. Before that,...

Current Market Cap

$5.79B

Number of Employees

23.5K

Total Compensation

2022 - 2023

Trending up by 165.46% last year
Showing total compensation for the last 2022 - 2023

Stock

Up by 0.00% last year

Salary

Up by 0.00% last year

Bonus

Up by 0.00% last year

Other

Up by 0.00% last year

Year

2023

Total Compensation

$2.65M

Salary

$1.00M

Board Justification

The compensation program aims to attract and retain superior executives, align pay with company performance, and reward individual and collective efforts that contribute to financial performance and stockholder value.

Bonus

$1.65M

Board Justification

Annual cash incentive based on performance metrics including Adjusted EBITDA and Adjusted EPS, achieving 132.3% of target for 2023.

Other

$962.00

Board Justification

Includes long-term care insurance benefits and 401(k) plan matching contributions.

Restricted Stock

$0.00(0 RSU)

Board Justification

No stock grants vested in 2023; however, performance-vesting restricted stock units are subject to future performance conditions and vesting periods.

Performance Metrics

Adjusted EBITDA and Adjusted EPS, with non-financial goals related to patient safety and technology initiatives.

SEC Filing

From April 9, 2024

Christopher H. Hunter

CEO of Acadia Healthcare

A

Education

Not available

Field of Expertise

Healthcare & Life Sciences - Healthcare

Born

January 1, 1970 - 54 years ago

Is Founder?

No

Current Tenure

2 years 5 months (Apr 2022 - Present)

Previous Experience

Executive and healthcare experience from prior senior leadership roles at Humana, TriZetto, and BlueCross BlueShield of Tennessee

View Holdings

Insider Holdings of Christopher H. Hunter

ACHCHUM

$12.31M

$1.82M (17.33%)

Last Insider Trade

ACHC

37,516 shares

ACHC

Jun 26, 2024

Received